Surya Pharmaceutical (Delisted) share news and announcements
BSE: 532516
Last traded ₹0.15 on 14 Sep 2015
Delisted on 11 May 2018.
Surya Pharmaceutical share news and announcements
400 announcements, routine notices left out, newest first. Page 2 of 8.
Aug 2013
19 Aug · Meeting
Company has fixed Book Closure from September 28, 2013 to September 30, 2013 for the purpose of Annual General Meeting to be held on September 30, 2013.16 Aug · Board meeting
14 Aug · Board meeting
The debts of the Company were restructured by its lenders under the Corporate Debt Restructuring (CDR) Scheme and the Master Reconstruction ....12 Aug · Updates
As per the audited Balance Sheet of the Company, as considered and approved by the Board of Directors of the Company in its meeting held on the July 20, 2013, the net worth of the Company stands completely eroded. The Company has, in terms of the provisions of the Sick Industrial Companies (Special Provisions) Act, 1985 (SICA), filed a Reference with the Board for Industrial and Financial Reconstruction (BIFR) for being declared a "sick Company" as per the provisions of SICA.8 Aug · Board meeting
Inter alia, to consider the followings :- (1) To take on record the un-audited Financial Results (Provisional) of the Company for the quarter ended June 30, 2013.(2) To consider and approve Book Closure of Register of Members and Share Transfer Books of the Company for the purpose of Annual General Meeting.7 Aug · Management
Mr. Dharam Pal Singhal, an Independent Director of the Company, resigned from the said office on June 15, 2013. The resignation of Mr. Dharam Pal Singhal was consequent to the resignations of Mr. Shiv Kumar Yadav (Independent Director) with effect from May 25, 2013 and Mr. Subhash Chander Marwaha (Nominee Director of SBI) with effect from May 29, 2013.As a result of the resignation of Mr. Dharam Pal Singhal, the total strength of the Board of Directors of the Company has reduced to two, which is less than the minimum number of Directors statutorily required for a public limited Company.The Board of Directors are making efforts to appoint a new person as a Director of the Company, which act is likely to take time as persons are unwilling to he appointed to office of Director of the Company due to actions initiated by certain creditors against the Company for winding up of the Company.7 Aug · Management
Mr. Dharam Pal Singhal, an Independent Director of the Company, resigned from the said office on June 15, 2013. The resignation of Mr. Dharam ....7 Aug · Updates
As per the audited Balance Sheet of the Company, as considered and approved by the Board of Directors of the Company in its meeting held on ....
Jul 2013
29 Jul · Change in Company Secretary/Compliance Officer
Consequent to the resignation of Mr. Bharat Bhushan Jain from the post of Chief Financial Officer & Company Secretary cum Compliance Officer of the Company with effect from May 28, 2013, the Company is in the process of appointing Company Secretary under the provisions of section 383A of the Companies Act, 1956, Till the time a Company Secretary is appointed, Sh. Rajiv Goyal, Chairman & Managing Director has been appointed as the Compliance Officer of the Company with effect from July 20, 2013 who shall liaison with the SEBI, Stock Exchanges, Registrar of Companies etc., and investors.26 Jul · Updates
Consequent to the resignation of Mr. Bharat Bhushan Jain from the post of Chief Financial Officer & Company Secretary cum Compliance Officer ....8 Jul · Board meeting
To consider and approve audited financial results of the Company for the year ended on March 31, 2013.
May 2013
31 May · Board meeting
22 May · Board meeting
To consider and approve Audited Financial Results i.e. Balance Sheet, Profit & Loss Account, Schedules and Notes thereon for the year ended March 31, 2013 of the Company.
Apr 2013
2 Apr · Updates
With reference to the earlier announcement with respect to approval of restructuring package by Corporate Debt Restructuring Empowered group (CDR-EG), the Company has now informed the Exchange that the master restructuring agreement (MRA) has been executed between the Company and lenders on March 31, 2013. The cut-off date for the CDR package is December 31, 2011. The CDR package envisages reduction in rate of Interest, deferment of payment of interest and principal amount of working capital facilities & term loans after a moratorium of 24 months from cut-off date.2 Apr · Updates
With reference to the earlier announcement with respect to approval of restructuring package by Corporate Debt Restructuring Empowered group (CDR-EG), Surya Pharmaceutical Ltd has now informed ....
Feb 2013
15 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 14, 2013 has transacted the following: (1). Mr. Subhash Chander Marwaha has been appointed as Nominee Director-SBl w.e.f. January 23, 2013.(2). Further in continuation of the Company's previous communication with respect to decision of State Bank of India (the lead bank) for restructuring of the Company's debt, it is hereby informed that the Corporate Debt Restructuring empowered group(CDR-EG) has approved the restructuring package and taken on record in the Board of Directors meeting held February 14, 2013.14 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 14, 2013, inter alia, has transacted the following: 1. Mr. Subhash ....5 Feb · Board meeting
To take on record the Un-audited Financial Results (Provisional) of the Company for the quarter ended December 31, 2012 along with Limited Review Report thereon.
Nov 2012
6 Nov · Board meeting
To take on record the un-audited Financial Results (Provisional) of the Company for the quarter ended September 30, 2012 along with Limited Review Report thereon.
Oct 2012
Sep 2012
Aug 2012
23 Aug · Meeting
Register of Members and Share Transfer Books of the Company shall remain closed from September 27, 2012 to September 29, 2012 for the purpose of Annual General Meeting to be held on September 29, 2012.